News
PPBT
0.5870
-2.49%
-0.0150
Weekly Report: what happened at PPBT last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at PPBT last week (0126-0130)?
Weekly Report · 02/02 09:48
Weekly Report: what happened at PPBT last week (0119-0123)?
Weekly Report · 01/26 09:49
Analysts’ Top Healthcare Picks: Purple Biotech (PPBT), Daiichi Sankyo Company (DSKYF)
TipRanks · 01/22 10:10
Weekly Report: what happened at PPBT last week (0112-0116)?
Weekly Report · 01/19 09:53
Purple Biotech Unveils January 2026 Corporate Update, Mapping 2026 Catalysts for CAPTN-3 and Oncology Pipeline
TipRanks · 01/13 11:30
Weekly Report: what happened at PPBT last week (0105-0109)?
Weekly Report · 01/12 09:51
Purple Biotech Reports Key Toxicology Milestone for CAPTN-3 Antibody IM1240
TipRanks · 01/07 13:36
Purple Biotech completes toxicology study of IM1240
TipRanks · 01/07 13:05
Purple Biotech Completes Non-Human Primates Toxicology Study Of IM1240
Benzinga · 01/07 13:05
Weekly Report: what happened at PPBT last week (1229-0102)?
Weekly Report · 01/05 09:48
Weekly Report: what happened at PPBT last week (1222-1226)?
Weekly Report · 12/29/2025 09:47
Weekly Report: what happened at PPBT last week (1215-1219)?
Weekly Report · 12/22/2025 09:47
Purple Biotech Shareholders Approve Key Proposals at December Meeting
TipRanks · 12/16/2025 21:28
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 12/16/2025 21:05
Purple Biotech Ltd. Held Extraordinary General Meeting of Shareholders
Reuters · 12/16/2025 21:01
Weekly Report: what happened at PPBT last week (1208-1212)?
Weekly Report · 12/15/2025 09:52
Purple Biotech Announces Positive Preclinical Data at ESMO IO Congress 2025
TipRanks · 12/11/2025 12:30
Purple Biotech’s antibody platform shows anti-tumor activity
TipRanks · 12/11/2025 12:26
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/11/2025 12:05
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.